Abstract
Background
Previous studies show that daily doses of 40–99 mg soy isoflavones produce inconsistent effects on preventing estrogen-related bone loss in postmenopausal women.
Aim of the study
To examined the bone-sparing effect of isoflavones at a higher dose in early Chinese postmenopausal women.
Methods
A total of 90 eligible women aged 45–60 years were randomly assigned to three treatment groups (30 subjects/group) with daily dosages of 0 (placebo), 84 and 126 mg isoflavones for 6 months. Further inclusion criteria included body mass index <30 kg/m2 and Kuppermann Climacteric Scale >15. Bone mineral density (BMD) of the spine and hip were measured using dual- energy X-ray absorptiometry at 0 and 6 months. Serum osteocalcin, bone-specific alkaline phosphatase (BAP) and urinary deoxypyridinoline were examined at 0, 3 and 6 months.
Results
Mean percent changes in BMD at the lumbar spine (p = 0.114) and femoral neck (p = 0.053) increased with the supplementations of soy isoflavones after adjusting for age, years since menopause, body weight and height, dietary intakes of isoflavones, calcium and protein, physical activities and baseline BMD at the relevant sites. We observed significantly dose-dependent linear relationship between the supplemental isoflavones and percent changes of BMD at the spine (p = 0.042) and femoral neck (p = 0.016) post-treatment, and urinary total deoxypyridinoline (p = 0.014) at 12 weeks but not at 24 weeks after adjusting for the above factors. No significant difference in percent changes in serum osteocalcin (p > 0.05) and BAP (p > 0.05) was found among the three treatment groups at 12-week and 24-week post-treatment.
Conclusion
There is a significantly dose-dependent effect of soy isoflavones on attenuating bone loss at the spine and femoral neck possibly via the inhibition of bone resorption in non-obese postmenopausal Chinese women with high Kuppermann Scale.
Similar content being viewed by others
References
Wasnich RD (1997) Epidemiology of osteoporosis in the United States of America. Osteoporos Int Suppl 3:S68–S72
Ho SC, Lau EM, Woo J, Sham A, Chan KM, Lee S, Leung PC (1999) The prevalence of osteoporosis in the Hong Kong Chinese female population. Maturitas 32:171–178
Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston CC, Kleerekoper M, Lindsay R, Luckey MM, McClung MR, Nankin HR, Petak SM, Recker RR (2001) American association of clinical endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 7:293–312
Xu H, Wu Y, Yan Y (1998) Preliminary study on bone loss rate in early and late stages of postmenopausal women. Chinese J Obstet Gynecol 33:542–545
Garg P, Kerlikowske K, Subak L, Grady D (1998) Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 92:472–479
Murkies AL, Wilcox G, Davis SR (1998) Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab 83:297–303
Greendale GA, FitzGerald G, Huang MH, Sternfeld B, Gold E, Seeman T, Sherman S, Sowers M (2002) Dietary soy isoflavones and bone mineral density: results from the study of women’s health across the nation. Am J Epidemiol 155:746–754
Mei J, Yeung SS, Kung AW (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86:5217–5221
Blum SC, Heaton SN, Bowman BM, Hegsted M, Miller SC (2003) Dietary soy protein maintains some indices of bone mineral density and bone formation in aged ovariectomized rats. J Nutr 133:1244–1249
Anderson JJ, Ambrose WW, Garner SC, Ohue T (2003) The effects of phytoestrogens on bone. Nutr Res 17:1617–1631
Shi LN, Su YX (2000) The effect of soybean isoflavones on bone loss in ovariectomized rat. Acta Nutrimenta Sinica 22:113–118
Anderson JJ, Anthony M, Messina MJ, Garner SC (1999) Effects of phyto-oestrogens on tissues. Nutr Res Rev 12:75–116
Anderson JJ, Ambrose WW, Garner SC (1998) Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 217:345–350
Arjmandi BH, Smith BJ (2002) Soy isoflavones’ osteoprotective role in postmenopausal women: mechanism of action. J Nutr Biochem 13:130–137
Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T (2000) Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844–852
Anderson JJ, Chen X, Boass A, Symons M, Kohlmeier M, Renner JB, Garner SC (2002) Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year. J Am Coll Nutr 21:388–393
Chen YM, Ho SC, Lam SSH, Ho SSS, Woo JLF (2003) Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88:4740–4747
Hsu CS, Shen WW, Hsueh YM, Yeh SL (2001) Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med 46:221–226
Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68:1375S–1379S
Kreijkamp-Kaspers S, Kok L, Grobbee DE, Haan EHF, Aleman A, Lampe JW, Schouw YT (2004) Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292:65–74
Setchell KD, Lydeking-Olsen E (2003) Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78:593S–609S
Wang HJ, Murphy PA (1994) Isoflavone content in commercial soybean foods. J Agric Food Chem 42:1666–1673
Huang MH, Harrison GC, Mohamed MM, Gombein JA, Henning SM, Go VL, Greendale GA (2000) Assessing the accuracy of a food frequency questionnaire for estimating usual intake of phytoestrogens. Nutr Cancer 37:145–154
Institute of Nutrition, Food Safety, China CDC (2002) China food composition 2002, 1st edn. Peking University Medical Press, Beijing, pp 24–219
Liu B, Woo J, Tang N, Ng K, Ip R, Yu A (2001) Assessment of total energy expenditure in a Chinese population by a physical activity questionnaire: examination of validity. Int J Food Sci Nutr 52:269–282
Behr W, Barnert J (1986) Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility. Clin Chem 32:1960–1966
Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA (2004) The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79(2):326–333
Ho SC, Chan SG, Yi Q, Wong E, Leung PC (2001) Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 16:1363–1369
Anderson JJ, Garner SC (1998) Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 12:543–557
Ho SC, Woo J, Lam SSH, Chen YM, Sham A, Lau J (2003) Soy protein consumption and bone mass in early postmenopausal Chinese women. Osteoporos Int 14:835–842
Springfield IL, Charles C, Thomas H (1973) Remodeling as a determinant of envelope physiology. In: Frost HM (ed) Bone remodeling and its relationship to metabolic bone disease. Orthopedic Lectures 28–53
Arjmandi BH, Khalil DA, Smith BJ, Lucas EA, Juma S, Payton ME, Wild RA (2003) Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 88:1048–1054
Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H (2000) Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 11:721–724
Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR, Kurzer M S (2000) Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 85:3043–3048
Barnes S (2003) Phyto-oestrogens and osteoporosis: what is a safe dose? Br J Nutr 89:S101–S108
Chen YM, Ho SC, Lam SS, Ho SS, Woo JL (2004) Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial. Menopause 11:246–254
Zhao G, Wang L, Yan R, Dennerstein L (2000) Menopausal symptoms: experience of Chinese women. Climacteric 3:135–44
Zhan S, Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:397–408
Acknowledgments
This study was jointly supported by Guangzhou Sciences and Technology Bureau (2002J1-C0081), and Acatris Holding B.V. The soy isoflavone extract was donated by Acatris Holding B.V., Giessen, The Netherlands.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ye, YB., Tang, XY., Verbruggen, M. et al. Soy isoflavones attenuate bone loss in early postmenopausal Chinese women. Eur J Nutr 45, 327–334 (2006). https://doi.org/10.1007/s00394-006-0602-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-006-0602-2